Immunigy is a branded powder-form oral gargle product described by its official website as an antibody-containing formulation supplied in single-use sachets. The product is intended to be mixed with water according to its product-specific directions. Its formulation, intended use, quality requirements, and regulatory status should be verified against current manufacturer documentation before commercial supply or publication.
Immunigy is associated with antibody-based oral product technology. The official product website describes a sachet-based powder that is reconstituted with water for oral gargle use. Because the product is a finished formulation rather than a single chemical ingredient, its quality and suitability must be evaluated using the complete product specification, ingredient declaration, manufacturing information, and applicable regulatory documentation.
The product's exact composition and permitted claims should be confirmed from current official sources. Historical product announcements and promotional descriptions do not independently establish current regulatory approval or clinical effectiveness.
The published product information describes Immunigy as a powder intended for reconstitution. A sachet format can help provide a premeasured quantity for preparation, while product-specific instructions determine the required volume of water, preparation method, use period after mixing, and disposal requirements.
The exact colour, flavour, powder characteristics, ingredient proportions, antibody concentration, and other quality attributes should be obtained from the current product specification. These details should not be inferred from images or from descriptions of other antibody-based products.
The official Immunigy website describes dissolving a 6 g sachet in 100 mL of water and using the prepared product within three hours. Always confirm the instructions printed on the current package and follow the authorised directions for the exact product supplied.
Preparation water, mixing procedures, the permitted period after reconstitution, and disposal of unused mixture should follow the product's current instructions. Do not substitute a preparation method from another product or formulation.
For product evaluation and responsible commercial listing, the following documentation may be requested from the authorised manufacturer or licence holder, where applicable:
The availability and applicability of each document must be confirmed with the responsible product company.
Immunigy is described as a single-use sachet product. Packaging details, pack size, shelf life, storage conditions, and transport requirements should be recorded exactly as stated in the current product documentation. Keep product packaging intact and consult the authorised instructions for handling and storage.
Immunigy has been promoted as an antibody-based product associated with COVID-19 management. Any statements about prevention, treatment, reduction of transmission, or clinical outcomes must be supported by reliable evidence and permitted under the current applicable regulatory authorisation. Historical promotional statements should not be presented as proof of effectiveness or current approval.
Before offering the product in India or another market, confirm its current legal status, intended classification, permitted claims, and relevant authorisations. Do not imply that the product is approved for a particular use without documentary verification.
Mediocon Inc. should be identified as the manufacturer only if it actually manufactures Immunigy and the relationship is documented. If Mediocon is an authorised distributor, reseller, or information provider instead, the page should accurately state that role. The brand's official website identifies Lay Sciences Inc., USA, as the licensing source.
Immunigy is a branded, sachet-based powder product described for oral gargle preparation. A reliable product listing should provide accurate formulation information, verified handling instructions, current technical documentation, and transparent regulatory details. Confirm all product claims and commercial relationships before publishing the page or accepting supply enquiries.
| Parameter | Specification |
|---|---|
| Appearance | Powder for oral gargle preparation |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Immunigy Oral Gargle Powder Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Immunigy Oral Gargle Powder Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance